Will Hims & Hers stock go up?

According to Danelfin AI, Hims & Hers has today an AI Score of 6/10 (Hold rating), because its probability of beating the market in 3 months (54.60%) is +3.78% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Hims & Hers stock?

The Hims & Hers target price is $36.81 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Hims & Hers stock right now?

Hims & Hers has today a Hold rating (AI Score 6/10), according to Danelfin AI. Its probability of beating the market in 3 months (54.60%) is +3.78% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Hims & Hers stock is a good buy .

Is Hims & Hers undervalued right now?

Based on analysts, the average price target downside for Hims & Hers is 0.00% (1Y). According to Danelfin AI, Hims & Hers has today an AI Score of 6/10 (Hold Rating).

What was the price range of Hims & Hers stock over the past 12 months?

The Hims & Hers stock price range over the past 12 months has been $14.52 - $66.18.

What is going on with Hims & Hers stock in the last 3 months?

The Hims & Hers stock performance in the last quarter has been +85.53%.

Does Hims & Hers offer dividend payments?

No, Hims & Hers does not currently pay dividends.

What is the current market capitalization of Hims & Hers?

Hims & Hers's market cap is $8.52B, as of 2026-07-03 08:00.

Hims & Hers Health Inc (HIMS) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

HIMS AI-Powered Stock Analysis

AI Score Explanation

AI Score

Hold

Fundamental
Technical
Sentiment
Low Risk

According to Danelfin’s proprietary AI model, Hims & Hers Health Inc today receives an AI Score of 6/10, which translates to a Hold rating. The stock has a 55% probability of outperforming the market in the next 3 months, which is 4% higher than the average probability of any stock (51%). Key positive contributors include the long tail of fundamentals impact (+1.93%), the 504-day chart pattern (+1.10%), and institutional transactions (3m change) (+0.67%), despite the latter being in the bottom 10%. On the negative side, the long tail of sentiment impact (-0.77%), the Fear & Greed Index at 31 (-0.50%), and maximum volatility in the top 20% (-0.44%) detract from the probability. Notable data points include institutional ownership at 65.91% (top 50%), which adds confidence, while the negative alpha last day (-1.90%, bottom 30%) and negative alpha 1Y (-43.84%, bottom 30%) suggest recent underperformance. The stock’s high beta of 2.30 (top 10%) and distance from KAMA (20d) in the top 10% indicate elevated risk and potential overextension. Overall, the AI model sees a balanced picture: positive fundamentals and chart patterns offset by high volatility and negative sentiment, resulting in a HOLD rating with a slightly above-average probability of outperformance.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Momentum+2.18%
Direction and strength of recent price movements
Valuation+2.01%
How the stock is priced relative to its fundamentals
Growth+0.67%
Expected pace of revenue and earnings expansion
Earnings Quality+0.35%
Stability and reliability of reported earnings
Size & Liquidity+0.20%
Company size and trading liquidity

Volatility-0.98%
How much the stock price tends to fluctuate
Sentiment-0.45%
How analysts and the market view the stock
Profitability-0.19%
Profitability and operating efficiency metrics

HIMS probability advantage of beating the market (3M):

+3.78%

Technical

Hims & Hers (HIMS) has a Technical Score of 10/10 because, according to only technical analysis, it has a probability advantage of +9.77% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.73%) and the probability of HIMS (60.49%) of overperforming the market in the next 3 months, as determined by Danelfin AI’s technical analysis.

Average probability of any US-listed stock of beating the market (3M)50.73%
HIMS probability advantage of beating the market (only technical, 3M)+9.77%
HIMS probability of beating the market (3M)60.49%

HIMS probability advantage of beating the market (only technical, 3M): +9.77%

The AI-powered technical analysis of Hims & Hers (HIMS) is only based on the 29 technical features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of HIMS:

Type	Alpha Signal	Probability Advantage Impact (3M)
Technical	Upgrade to Pro to unlock	+2.80%
Technical	Upgrade to Pro to unlock	+1.84%
Technical	Upgrade to Pro to unlock	+1.74%
Technical	Upgrade to Pro to unlock	+1.41%
Technical	Upgrade to Pro to unlock	-1.23%
Technical	Upgrade to Pro to unlock	+0.99%
Technical	Upgrade to Pro to unlock	+0.85%
Technical	Upgrade to Pro to unlock	+0.74%
Technical	Upgrade to Pro to unlock	+0.59%
Technical	Upgrade to Pro to unlock	+0.42%
Technical	Upgrade to Pro to unlock	+0.39%
Technical	Upgrade to Pro to unlock	-0.34%
Technical	Upgrade to Pro to unlock	+0.33%
Technical	Upgrade to Pro to unlock	-0.33%
Technical	Upgrade to Pro to unlock	-0.32%

Rest of Alpha Signals: +1.42%

HIMS probability advantage of beating the market (only technical, 3M)Total:+9.77%
HIMS Technical Score

Significant changes Vs previous day

HIMS Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$36.81
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

HIMS Proven Hold Signal & Price Forecast

This is the price chart for HIMS from January 2, 2026 until today. The chart indicates, in yellow, the 97 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

HIMS Average Past Performance & Win Rate

Three months after its 1012 Hold signals since July 2026, HIMS had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

1012 Past HIMS Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+47.02%
Average Alpha				+29.51%
Win Rate (% Positive Perf.)				62.44%
% Positive Alpha				50.77%

HIMS Frequently Asked Questions

Will Hims & Hers stock go up?
According to Danelfin AI, Hims & Hers has today an AI Score of 6/10 (Hold rating), because its probability of beating the market in 3 months (54.60%) is +3.78% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Hims & Hers stock?
Is it a good time to buy, sell, or hold Hims & Hers stock right now?
Is Hims & Hers undervalued right now?
What was the price range of Hims & Hers stock over the past 12 months?
What is going on with Hims & Hers stock in the last 3 months?
Does Hims & Hers offer dividend payments?
What is the current market capitalization of Hims & Hers?

Hims & Hers Health Inc Company Profile

Hims & Hers Health, Inc. is a pioneering entity in the world of telehealth, where it seamlessly and securely connects consumers with licensed healthcare professionals from across the United States, United Kingdom, and global territories. Its sophisticated virtual platform boasts a rich selection of prescription-based as well as over-the-counter health and wellness products available for instantaneous purchasing for its users via its user-friendly websites and mobile application.

Additionally, the company specializes in providing continual healthcare and service through recurring prescription medications managed by healthcare providers. Their offerings extend beyond just medications to include non-prescription wellness goods that range from general cosmetics to sexual health supplements. The wellness specialties are populated by carefully selected items such as melatonin and biotin.

For skincare enthusiasts, it curates products like moisturizers, creams, sunscreen among others. In the realm of sexual health and wellness specialty, they offer diverse products including condoms and lubricants; while their hair care specialty category houses treatments using minoxidil alongside conventional shampoos.

Moreover, Hims & Hers Health further complements its comprehensive service portfolio by offering medical consultation services along with dedicated post-consultation support services. Launching itself as a wholesale partner too, it offers access to an array of health and wellness items through business partnerships.

The San Francisco-based organization is committed to expanding its consumer-friendly telehealth approach in ensuring optimal holistic well-being among users around the globe.

Sector:Health Care
Country:United States
Industry:Health Care Providers & Services
Address:2269 Chestnut St, #523, San Francisco
Employees:2,442
Website:forhims.com

Pros

Recurring revenue from subscription-based model

Direct-to-consumer distribution channel efficiency

Scalability of telehealth platform infrastructure

Expansion potential into adjacent health categories

Personalized treatment plans leveraging user data

Cons

Evolving regulatory landscape for telehealth and pharmacy

High customer acquisition costs in competitive digital advertising

Competition from traditional and specialized telehealth providers

Dependency on third-party pharmacy and prescriber networks

Demand sensitivity for elective health and wellness services

Pros

Cons

Company

AI Score

Compare

HSTMHealthStream Inc

HNGEHinge Health Inc

HQYHealthequity Inc

LFMDLifeMD Inc

MNDRMobile-health Network Solutions

Company

AI Score

Compare

HIMS Top 10 Industry Stocks

Health Care Providers & Services

	Company	AI Score	Compare
1	ENSGEnsign Group Inc
2	BKDBrookdale Senior Living Inc
3	NHCNational Healthcare Corp
4	VMDViemed Healthcare Inc
5	EHCEncompass Health Corp
6	HCAHCA Healthcare Inc
7	MCKMcKesson Corp
8	ARDTArdent Health Inc
9	NUTXNutex Health Inc
10	GRDNGuardian Pharmacy Services Inc

	Company	AI Score	Compare

	Company	AI Score	Compare
1	COGTCogent Biosciences Inc

Company

AI Score

Compare

COGTCogent Biosciences Inc

Company

AI Score

Compare

HIMS Stock AI Analysis